AITRICS VCLIFE SCIENCE & HEALTHCAREAI powered healthcare solution provider

AITRICS is a Seoul-based medical artificial intelligence company that develops AI-powered software to support clinicians in detecting and preventing critical patient deterioration. Its flagship product, AITRICS-VC (VitalCare), analyzes real-time electronic medical record (EMR) data using deep learning to predict adverse patient events including sepsis, acute kidney injury, and respiratory deterioration in hospital settings. The system is deployed in ICUs and general wards, integrating with existing hospital IT infrastructure to provide early warning scores and clinical decision support. AITRICS has partnerships with Mayo Clinic and has obtained medical device regulatory approvals in multiple countries including Malaysia and Indonesia in 2026. The company has published research at leading venues including ACL and BioNLP and has established a Japanese subsidiary conducting joint research with Yokohama City University Hospital. Founded in 2016 by Eunho Yang and Kwang Joon Kim, AITRICS has raised over $44 million in total funding including a Series C of KRW 35 billion ($23.7M) closed in December 2025.